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Abstract 1 
BACKGROUND: Changes in glycosylation profiles of monoclonal antibodies can 2 
have significant impact upon the product quality. Control of critical process 3 
parameters in order to ensure consistent product quality is one of the core 4 
requirements of the FDA’s QbD and PAT initiatives. The effect of operating 5 
conditions upon cell metabolism and the glycosylation profile of monoclonal antibody 6 
produced using hybridoma cell culture is investigated in this report. 7 
RESULTS: PCA analysis of on-line process data and amino acid concentration 8 
profiles reflecting the cell metabolism indicates significant dependence on the 9 
operating conditions, particularly DO and pH. PLS models predicting product titre 10 
based on amino acid concentration and those predicting the glycosylation profile 11 
either based on product titre and glucose concentration or on amino acid 12 
concentrations show that both titre and glycosylation can be predicted with 13 
satisfactory accuracy for a range of operating conditions. 14 
CONCLUSIONS: Accurate prediction of product titre and glycosylation profile based 15 
on amino acid concentration and process variables easily measured in real time 16 
opens up the opportunity to control the product quantity and quality during cultivation 17 
using critical process parameters, such as pH and DO.  18 
 19 
 20 
 21 
 22 
 23 
  24 
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Introduction 1 
In 2004 the FDA (Food and Drug Administration) introduced the Process Analytical 2 
Technology (PAT) guidance and Quality by Design (QbD) initiative. They aim for the 3 
biopharmaceutical industry to implement a system for designing, analysing and 4 
controlling critical quality attributes (CQAs) through critical process parameters 5 
(CPPs) to ensure final product quality and increase yields (1). The identification and 6 
subsequent control of the parameters which have the greatest influence over the 7 
system, to establish robust and well controlled processes, are some of the main 8 
challenges faced by industry. QbD and PAT have been applied to laboratory scale 9 
fermentations of bacterial expression systems showing the benefits of applying these 10 
approaches to the more complex mammalian-cell expression systems (2-4). 11 
Historically, development of mammalian cell culture has focused on cell line and 12 
culture improvements and the PAT principles have yet to be widely adopted in this 13 
area by the biopharmaceutical industry (3, 4).  14 
Multivariate data analysis (MVDA, see below) has been shown to be able to extract 15 
important process information from data sets and to reduce the complexity of the 16 
data set by eliminating co-linearity and noise. (4-7). Given these characteristics, 17 
MVDA has the potential to help in the identification of CQAs in line with the QbD and 18 
PAT requirements. However, the process/product complexity, changing cultivation 19 
environment over the cultivation trajectory and the lack of direct signal to 20 
physiological mechanism relevance increases the challenge in applying PAT 21 
methods (8). 22 
On the other hand, recent reports in the literature indicate increasing levels of 23 
understanding the cellular metabolism and the impact of the changes in 24 
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environmental conditions both on cell metabolism and product quality (9-13). This 1 
strengthens the motivation to develop accurate dynamic models combining the 2 
proven ability of data-based models to predict important process variables based on 3 
process data readily measured during the cultivation with first principles 4 
understanding of cell metabolism and product synthesis. 5 
Recent studies, e.g. Grainger and James, describe the effect of media composition 6 
upon glycosylation (14). The authors demonstrated that through response surface 7 
modelling of a design of experiments (DoE), predictions can be made of the 8 
response of the glycosylation. This suggests that further information could be gained 9 
from adopting a statistical analysis of culture conditions. Currently modelling efforts 10 
are focused on the characterisation of the metabolic pathways associated with 11 
glycosylation (15). In addition to this a recent study by Amand et al. has shown that 12 
whilst there are currently no online control schemes in place, there is the potential for 13 
development of online glycosylation control (16). 14 
The research reported here investigates the link between process operating 15 
conditions, cell metabolism and the production of different glycosylated forms of a 16 
monoclonal antibody (mAb) produced by  a murine hybridoma cell line as a first step 17 
towards formulating such combined hybrid models (17). A set of 12 cultivations was 18 
selected for model development. Advanced data analysis methods as described 19 
below were used initially to provide indications of the influence of operating 20 
conditions upon cell growth, product yield and quality. Relationships between the 21 
metabolism, as reflected by the amino acid concentrations throughout the cultivation, 22 
and the process performance were then explored with the aim of ultimately 23 
combining first principle knowledge and data-based models in a hybrid modelling 24 
structure providing a more accurate process representation. Within the multivariate 25 
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techniques Parallel Factor Analysis (PARAFAC) and Multi-way Principal Component 1 
Analysis (PCA) were applied to analyse the interactions within the cultivation. Partial 2 
Least Squares (PLS) and Multi-way PLS were then applied to investigate the 3 
influence of the controlled cultivation conditions upon the product quality 4 
(glycosylation profile) and quantity (titre).  5 
Overview of data analysis techniques 6 
Three complementary techniques were used to enable the investigation of the 7 
relationships between the different measured variables and subsequently the 8 
prediction of the mAb glycosylation pattern. 9 
Parallel Factor Analysis (PARAFAC) 10 
PARAFAC is a generalisation of PCA for higher order arrays (18). With PARAFAC 11 
there is no rotation problem, which is beneficial for data sets such as that being 12 
investigated in this study where batch length and sampling intervals are irregular. 13 
PARAFAC allows for the visualisation of the data in a way that is relative to the raw 14 
information, therefore making it useful as a precursor to Principal Component 15 
Analysis (18). Details of the methodology for the decomposition of the data into the 16 
components can be found in the work of Rasmus Bro (18). 17 
Principal Component Analysis (PCA) and Multi-way PCA (MPCA) 18 
PCA reduces the dimensionality of the data set through turning the noisy data and 19 
correlated process measurements into a smaller set of latent variables. These latent 20 
variables (principal components) are expressions of the linear combinations of the 21 
input variables and the corresponding weights (loadings). The first few principal 22 
components (PCs) capture most of the variance and if the original measurements 23 
are highly correlated then the data set can be represented using fewer PCs without a 24 
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significant loss of information. In this contribution a multi-way PCA (MPCA) is used to 1 
account for the batch character of the process data collected (19). 2 
This study uses time trajectories of various online and offline measurements (as 3 
described in the methods section) measured from numerous cultivations (see Table 4 
1). Thus the data represent a three way array with time, variables and cultivation 5 
runs representing the three dimensions of the array. There are various ways in which 6 
this array can be unfolded to form a two dimensional matrix for classical PCA 7 
analysis. Albert and Kinley discuss the advantages of each method in more detail 8 
(6).  9 
Partial Least Squares (PLS) and Multi-way PLS (MPLS) 10 
PLS is able to cope with collinear input and output variables and consider the 11 
covariance in the data. PLS is closely related to PCA, although as a regression 12 
technique, it simultaneously finds latent variables for both the input and the output 13 
measurements that best capture the influence of the variability in the input data upon 14 
the process output. The main advantage of PLS is that outputs of the system can be 15 
calculated from only a few latent variables (LVs), which capture the maximum 16 
variance in the system.  17 
The main difference between PLS and PCA is that in PLS every observation in the 18 
data sets is represented in both the input and output space. The scores are 19 
calculated so that they maximise the approximation of both the input and the output 20 
data sets and furthermore so that the correlation between them is maximised. The 21 
loadings in PLS provide information about how the variables combine to give the 22 
scores values. They are an indication of how important these variables are in the 23 
prediction of the modelled process outputs. 24 
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Similarly as in the case of MPCA, MPLS decomposes the three way array into a two 1 
dimensional matrix. Nomikos et al. and Cunha et al. present the details of the 2 
methodology for the decomposition and for correlating the resulting matrices (20, 3 
21). 4 
Methodology 5 
Experimental procedure 6 
A hybridoma cell line (ATCC CRL-1606) was used in this work. The cell line was 7 
adapted to chemically defined culture media (TurboDoma TP6, Cell Culture 8 
Technologies) and cultivated in controlled parallel bioreactors (DasGip) in batch 9 
mode. The culture conditions have been reported earlier (22). Briefly, culture 10 
environment was controlled at 37 °C, dissolved oxygen (DO) was set to 50% air 11 
saturation and controlled by a constant gas inlet flow rate of 0.05 vvm. pH was equal 12 
to 7.2, stirrer speed set to 150 rpm and osmolarity around 320 mOsm/kg. A 13 
parameter shift of one of the process control parameters was performed in the early 14 
exponential growth phase as described earlier together with the sampling procedure 15 
and analytical methods (22). Viable cell concentration, glucose, lactate and ammonia 16 
concentrations, amino acid concentrations, mAb concentrations and the 17 
glycosylation profile were measured twice a day as offline data. Briefly, glucose and 18 
lactate concentrations were determined enzymatically using a Hitado Super GL 19 
compact instrument (Hitado, Germany). Ammonium and glutamine concentrations 20 
were determined using the L-Glutamine/Ammonia (Rapid) Assay Kit (Megazyme, 21 
Ireland). Samples were spun down and supernatants were stored at -20 °C and later 22 
used for measurement of antibody concentration (PA ImmunoDetection® Sensor 23 
Cartridge, Applied Biosystems, USA) and N-linked glycosylation analysis. For the 24 
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glycosylation analyses, the mAB samples were purified using the Vivapure® 1 
miniprepG purification kit (Satorius Stedim Biotech, France) and enzymatically 2 
deglycosylated by N-glycosidase F (PNGase F glycerol free) (New England Biolabs, 3 
USA). N-linked oligosaccharides were fluorescently labeled, separated using Agilent 4 
1200 HPLC system (Agilent Technologies, USA) equipped with a fluorescence 5 
detector for analysis by hydrophilic interaction chromatography (HILIC) using a 6 
GlykoSep N-Plus column (4.6 mm x 150 mm, Prozyme, USA) and analysed by 7 
Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF) Mass 8 
Spectrometry (MS) as detailed previously (22). The profiles of temperature, 9 
dissolved oxygen, pH, stirring speed and gas flow rate, together with the gas inlet 10 
fractions of oxygen (O2) for DO control and carbon dioxide (CO2) and the base 11 
addition volume used for pH control were recorded online over the whole culture.  12 
Multivariate methodology 13 
The multivariate statistical analysis carried out in this contribution was performed 14 
using the program MATLAB (Math Works, Inc.) with the software PLS toolbox 15 
(Eigenvector Research, Inc.).  16 
To perform the PCA analysis 12 experimental cultivations were used. The conditions 17 
of the cultivations can be seen in Table 1. The online process data used in the 18 
analyses included dissolved oxygen (DO), gas inlet fraction of oxygen (O2) and 19 
carbon dioxide (CO2), volume of base addition, pH, temperature, stirrer speed, and 20 
gas inlet flow rate. The offline variables included viable cell concentration, total cell 21 
concentration and titre. The amino acid data included the concentrations of the 22 
twenty amino acids and ammonia at 11 sampling time points during the cultivation. 23 
Finally the glycosylation was recorded at the end of the cultivation and the 24 
concentrations of nine glycan forms were expressed as a percentage of peak area 25 
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(see Experimental procedure). The number of PCs and LVs retained in the models 1 
was chosen based on the Kaiser-Guttman method (23) to capture the greatest 2 
variation in the data whilst maintaining model robustness. According to this method, 3 
PCs or LVs with an eigenvalue greater than 1 were retained in the model (see Table 4 
3 for details on the number of PCs and LVs retained in the models). For PCA a 5 
comparison of two analyses was performed. The analysis of the whole cultivation 6 
data from inoculation to the end of the cultivation was compared with the trends 7 
observed from data collected after the shift in the relevant process operating 8 
parameter until the end of the cultivation (referred to as ‘post shift’ hereafter). 9 
The PLS models were developed using the same experimental data with the 10 
exception that one of the runs used for PCA model development was instead used 11 
as a validation run. Therefore 11 runs were used to build the PLS models (Table 2: 12 
runs 1-4 and 6-12) and 2 runs to validate (Table 2: runs 5 and 13).This was caused 13 
by the unavailability of glycosylation data for one of the validation runs used in the 14 
MPCA analysis. The SIMPLS algorithm (24) within the PLS toolbox with ‘leave one 15 
out’ cross validation method minimising the Root Mean Square Error of Cross 16 
Validation (RMSECV) was used. The data was first autoscaled (the mean value of 17 
each column removed from each value and divided by the standard deviation of the 18 
column). Model performance is reported in terms of average Root Mean Square 19 
Error (RMSE) over the duration of the cultivation post shift for the validation batches 20 
(Table 2) for the prediction of titre. In the case of the glycosylation prediction, the 21 
average RMSE over the two validation runs for each glycan form concentration at 22 
the end of the cultivation is reported in Table 3. 23 
RMSE is defined as the measure of the differences between the values predicted by 24 
a model and those observed from experimentation. 25 
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𝑅𝑀𝑆𝐸(𝑦�) =  �∑ (𝑦𝑖−𝑦�𝑖)2𝑛𝑖=1
𝑛
        (1) 1 
where 𝑦�𝑖 is the predicted value of 𝑦𝑖 and n is the number of measurements. 2 
This error criterion is frequently used in modelling to report model performance as it 3 
has the same units as the quantity being estimated and thus allows comparison of 4 
models predicting the same output variable as they all relate to the same 𝑦𝑖. 5 
Results and Discussion 6 
The cultivation conditions for the experimental cultivations used in this report were 7 
varied as summarised in Table 1 and 2. There are four groups, each consisting of 8 
three runs which investigate the influence of individual process parameters upon the 9 
quality and the quantity of the produced mAb.  10 
Parallel Factor Analysis (PARAFAC) 11 
The parallel factor analysis was carried out first to assess the interactions in the raw 12 
data using data from runs 1 to 12 described in Table 1. The data was arranged in a 13 
three way array with time, batches and variables representing the dimensions, 14 
respectively. Where batch lengths were unequal, ‘not a number’ was entered. To 15 
construct the PARAFAC analysis, the PARAFAC function within the PLS toolbox was 16 
used with three components. This was selected as the analysis was shown to 17 
explain the effects of interest i.e. the constructed model was shown to explain 18 
variability in cultivation duration (Figure 1S plate A in the supplementary material), 19 
variables (Figure 1S plate B) and batches (Figure 1S plate C). Using more 20 
components did not yield any further useful observations.  21 
The analysis indicated that PARAFAC can capture the variation in the system and 22 
the controlled parameter shift at 30 hours. Figure 1S plate A demonstrates this shift 23 
Page 11 of 32 
 
in the Mode 1 of the model for each of the three components. PARAFAC was 1 
especially beneficial in assessing the quality of the experimental runs as it 2 
highlighted specific runs deviating from the typical observed behaviour (as illustrated 3 
by Figure 1S plate C). However this deviation is not excessive and can be explained 4 
by the different operational conditions each experiment operated under. Figure 1S 5 
(C) shows that of the 12 batches used in the analysis (Table 1), batch 9 is 6 
highlighted as exhibiting different behaviour. This batch was carried out with a pH 7 
shift to a high value at 30 hours. Subsequent analyses also highlighted the different 8 
behaviour of this batch (see results of PCA below and a possible hypothesis for this 9 
behaviour). 10 
Multi-way Principal Component Analysis (MPCA) 11 
Online data analysis 12 
Figure 1 shows the bivariate scores plots of MPCA analysis based on on-line data 13 
only, with each batch represented by one symbol, depending on the operating 14 
parameter shift in that batch (see Table 1 for conditions and Figure 1 legend for 15 
symbols used for each parameter shift). Figure 1 demonstrates that there is distinct 16 
clustering of data recorded from batches carried out under various cultivation 17 
conditions. By comparing graphs A-C and D-F it can be seen that the PCA carried 18 
out with the data from the whole cultivation and the PCA carried out only using the 19 
post shift data present different results due to the variability introduced by pre-shift 20 
data. This variability in pre-shift data is caused by slight differences during the 21 
inoculation procedure in the bioreactor and results in a growth lag-phase observed in 22 
the first 24 hours of the culture. As only the post-shift data is of interest in this case 23 
since this study is investigating solely the impact of the change in operating variables 24 
upon the process performance, all subsequent discussions will concentrate on the 25 
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analysis of post-shift results. The highest DO concentration (90%) is indicated to 1 
display a different behaviour compared to the two cultivations carried out at lower 2 
DO concentrations (50 and 10%) as it is placed in the opposite quadrant to these 3 
(see square symbols in Figure 1 D-F). This appears to indicate a negative influence 4 
of high DO values on the process, which is in line with observations of Tummer et al. 5 
(11). Similar observations can be made in terms of the effect of pH with batches 6 
carried out at different pH post shift being placed in opposite quadrants (see circle 7 
symbols in Figure 1 D-F). Ivarsson et al (22) discuss in detail particularly the 8 
negative impact of high pH upon the process performance. PC4-PC6 (not shown) do 9 
not show any unexpected results with the cultivations equally distributed and 10 
grouped by cultivation condition.  11 
Amino acid data 12 
In order to explore the metabolic activity of the cells during the cultivation, samples 13 
were analysed to establish the concentrations of all twenty amino acids and 14 
ammonia. In the initial analyses ammonia was indicated as an extreme outlier, 15 
limiting the possibility to explore the relationships between the amino acid 16 
concentrations. Given the analytical measurement inaccuracies for this variable, it 17 
was removed from further analyses.  18 
The PCA analysis of the amino acid data showed that 4 principal components 19 
captured over 90% of the variation in the data (PC1 explaining 53.79%, PC2 20 
20.52%, PC3 10.49% and PC4 6.97%). Figure 2 shows the bivariate score plots for 21 
the amino acid data. It is interesting to note that experimental runs with DO 22 
variations are very tightly clustered showing very similar amino acids patterns 23 
independent of DO concentration. Similarly, the cultivations carried out under varying 24 
sparger settings are also clustered together which shows this operating parameter 25 
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does not appear to influence the metabolic state as reflected by the amino acid 1 
composition. In contrast the pH cultivations show a spread indicating that the amino 2 
acids are sensitive to the operating pH, as reported in the literature previously, e.g. 3 
(25). This spread is particularly dominant in the direction of the PC2, indicating that 4 
this PC is influenced mainly by the pH. As PC1-3 are all highly influenced by pH, it 5 
suggests that pH is a critical factor in amino acid metabolism. Higher PCs (not 6 
shown) did not show further significant effects on the analysis. 7 
An analysis was then performed to consider individual amino acid profiles per batch 8 
to explore the contributions of these towards the patterns described above. Figure 3 9 
shows the bivariate plots of coefficients (loadings) of the first three PCs, colour 10 
coded according to the experimental run to which they relate (Table 1). The 11 
coefficients indicate that the individual amino acids did not show any particular 12 
patterning implying that all amino acids exhibit similar influence on the principal 13 
components. It is the higher principal components which are of more interest. For 14 
PCs 2 and 3 experimental runs 1-3 and 9-12 (DO shift to 50%, 10%, 90% and 15 
sparger settings 0.005 vvm, 0.1 vvm and 0.2 vvm, respectively) show distinct 16 
grouping, suggesting distinct patterns in amino acid profiles in these batches that are 17 
different compared to batches 4-8 (osmolarity shift to 350, 380 and 450 mOsm/kg 18 
and pH shift to 7.0 and 7.5, respectively) showing no distinct patterning. Interestingly, 19 
cultivation 9 in which pH was shifted to 8.0 behaves differently to the other two pH 20 
shift cultivations and this is in line with the observations reported earlier (22). Since 21 
PCs 2 and 3 account for approximately 21% and 10% of the variation, respectively, 22 
the cause of this variation can still be said to be significant. Therefore, since 23 
osmolarity and pH experiments are shown to result in such spread of amino acid 24 
data, it suggests that these two process operating parameters need to be optimised 25 
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to achieve better control of the metabolic state of the culture. Furthermore, previous 1 
studies have shown that DO and sparger do not have a significant impact on growth 2 
rate within the ranges investigated in this research (22).  3 
Partial Least Squares (PLS) and Multi-way PLS 4 
The model structures and performance of each of the PLS models developed in this 5 
study are summarised in Table 4 showing the input and output data for each model, 6 
average RMSE error for the two validation runs over the duration of cultivation post 7 
shift and the number of latent variables used in the model. For glycosylation pattern 8 
prediction, average RMSE values over the two validation runs are shown individually 9 
for each glycan to enable the relative accuracy of the model to be evaluated. 10 
Titre 11 
Partial Least squares (PLS) method was used to investigate whether the amino acid 12 
data could be used to predict product titre. Whilst the standard approach of using on-13 
line data to predict the titre was also used (data not reported here), by using amino 14 
acid data as model inputs, the relationship between the metabolic state and the 15 
product quantity can be explored. The model consisted of four latent variables (LVs), 16 
which accounted for 95.83% of the cumulative variance in the input data and 99.41% 17 
of the cumulative variance in the output data. Cross-validation results indicated that 18 
lower numbers of LVs resulted in a significantly reduced accuracy of prediction. 19 
The model was constructed to predict the titre at various time points throughout the 20 
cultivation based on amino acid data only. Figure 4 shows the titre predictions of the 21 
resulting models for the two validation runs (circles and squares) together with the 22 
experimental error bars. Except for the time points around 10 and 20 hours post shift 23 
(sample points 3-5), the model provides satisfactory prediction of the titre based only 24 
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on the amino acid concentration data collected post shift until the end of the 1 
cultivation. The prediction inaccuracy following the shift in operating parameters may 2 
be related to the significant changes in the amino acid profiles post shift, as indicated 3 
by the PCA analysis (Figures 2 and 3). In particular the depletion of glutamine at this 4 
stage in the cultivation will have a significant impact upon the analysis. 5 
Glycosylation 6 
MPLS was used to investigate the relationship between a matrix consisting of titre 7 
(Model 1) and titre and glucose measurements (Model 2) over the duration of the 8 
cultivation post-shift and the glycosylation patterns of the product at the end of the 9 
cultivation. A model was also constructed considering amino acid data used to 10 
predict the concentration of the nine glycan forms measured (Model 3). Finally, a 11 
model using on-line data only to predict the concentration of the glycan forms (Model 12 
4) was also developed. In each case the cross-validation determined the optimum 13 
number of latent variables to be four and the percentage of the variance in the input 14 
and output data is listed in Table 3 for each of these models. 15 
Figures 5 and 6 show the predictions of the glycosylation prediction models (Model 2 16 
and Model 3), respectively, for the two validation runs (open symbols) along with the 17 
predictions for the 11 training runs (black symbols) for individual glycan forms (A – I). 18 
Model 3 resulted in the lowest RMSE over all the glycan forms for the two validation 19 
runs (0.75) compared to Model 2 (1.43), Model 1 (3.82) and Model 4 (13.78). Clearly 20 
with only two validation batches it is more difficult to select the ‘best’ performing 21 
model as the predictions for one of the validation batches is frequently more 22 
accurate than for the other batch. Model 3 and Model 2 predictions were selected 23 
here to demonstrate the ability of the Model 3 to predict some of the glycan forms 24 
more accurately than models based on titre (with or without glucose) did. Figure 5D 25 
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illustrates this issue with prediction accuracy in terms of the concentration of 1 
glycoprotein G2F, although when amino acid data is used as input instead of the titre 2 
and glucose, this inaccuracy is significantly reduced (Figure 6D). This indicates that 3 
both titre together with glucose concentration and amino acid concentrations show 4 
satisfactory ability to predict the concentrations of the majority of glycan forms of the 5 
product at the end of the cultivation. Since glycosylation is directly correlated to the 6 
titre and the availability of glucose is a prerequisite for the availability of nucleotide 7 
sugar donors, one would expect significantly better prediction accuracy for Model 2 8 
compared to the other models. The investigated batch runs, however, are not limited 9 
by glucose and mAb productivity is rather low. Therefore, these two parameters do 10 
not seem be better suited than the amino acid data to predict the glycosylation data. 11 
Although using amino acid data to predict glycosylation would initially appear counter 12 
intuitive, the relatively rapid analytical technique compared to the system dynamics 13 
would still enable in-time control action, which may prove to be more accurate as it is 14 
based on a measurement reflecting a metabolic state of the culture. 15 
Ideally, Model 4, based on on-line data only would be most valuable in a PAT based 16 
on-line control scheme. However, as Table 3 and Figure 2S (supplementary 17 
material) indicate, the on-line data is not sufficient to provide an accurate estimate of 18 
the glycosylation profiles. It can be argued that in order to develop models that 19 
enable control of the glycosylation profiles using the standard control variables, an 20 
in-depth understanding of the mechanisms involved in the cell metabolism is 21 
required. First principles models can be used to elucidate the metabolic processes 22 
and their impact upon the final glycoprotein production. When combined with 23 
multivariate data analysis models, such as PLS demonstrated in this study, the 24 
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resulting hybrid models have the potential to offer better prediction and control of 1 
mammalian cell cultivations (17).  2 
Furthermore in comparing the RMSE values shown in Table 4 and the predictions of 3 
the models shown in Figures 5, 6, and 2S it can be seen that there might be benefit 4 
in constructing models to individually predict each glycoprotein. This would allow for 5 
the exploration of issues in prediction accuracy and thus aid in elucidating the 6 
underlining mechanisms of formation and the correlations between the input and 7 
output variables. 8 
Concluding remarks 9 
This study has presented an analysis and demonstrated the need for monitoring and 10 
control of glycosylation in mammalian cell culture where culture conditions might be 11 
varied. The exploratory analysis using PARAFAC and (M)PCA techniques indicated 12 
that the response of the culture to the shift in individual operating parameters can be 13 
captured using these techniques and the emerging multivariate patterns can be 14 
correlated to the most influential process parameters. In the online data patterns the 15 
shifts in pH and DO resulted in the most distinctive patterns. As far as the impact 16 
upon the cell metabolism, as reflected by the amino acid concentration data, is 17 
concerned, the clear influence of pH and partially that of osmolarity shift was 18 
highlighted, whereas the influence of the dissolved oxygen and sparger setting shifts 19 
was not detectable over the range of the settings investigated in this research. PLS 20 
and MPLS models have demonstrated the ability to predict the mAb titre from the 21 
amino acid data as well as the ability to predict the concentration of various 22 
glycosylation forms of the product at the end of the cultivation either based on the 23 
titre and glucose concentration data or using the amino acid data. However, the 24 
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glycosylation prediction based on on-line data only resulted in a poor model 1 
prediction performance. This indicates that relying purely on on-line data may not be 2 
sufficient when product quality is to be controlled and additional knowledge is 3 
required. 4 
The next stage of this research will explore the incorporation of first principles 5 
models via an agent based system (26) to investigate whether better understanding 6 
of cellular metabolism can aid in the prediction of glycoproteins. The intention is to 7 
use these first principles models to provide the link between the standard online 8 
monitoring system and the offline measurements which can be used to control 9 
glycosylation. The overall aim of the project is to then take this framework and apply 10 
it to both the upstream and the downstream in order to optimise the entire process. 11 
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Table 1: Experimental conditions of each of the 12 experimental runs used in the PCA 1 
analysis. Numbers highlighted in bold show the parameter and value to which that 2 
parameter was shifted at 30 hours into the cultivation. Prior to the parameter shift the 3 
cultivations were operated at a standard setting (50% dissolved oxygen; 380 4 
mOsm/kg osmolality; 7.2 pH; 0.05 vvm sparging). 5 
Run identifier Dissolved 
oxygen (%) 
Osmolality 
(mOsm/kg) 
pH Sparging (vvm) 
Run 1 50 380 7.2 0.05 
Run 2 10 380 7.2 0.05 
Run 3 90 380 7.2 0.05 
Run 4 50 350 7.2 0.05 
Run 5 50 380 7.2 0.05 
Run 6 50 450 7.2 0.05 
Run 7 50 380 7.0 0.05 
Run 8 50 380 7.5 0.05 
Run 9 50 380 8.0 0.05 
Run 10 50 380 7.2 0.05 
Run 11 50 380 7.2 0.10 
Run 12 50 380 7.2 0.20 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
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Table 2: Experimental conditions of each of the 13 experimental runs used to construct and 1 
validate the PLS models. Numbers highlighted in bold show the parameter and value to 2 
which that parameter was shifted at 30 hours into the cultivation. Prior to the 3 
parameter shift the cultivations were operated at a standard setting (50% dissolved 4 
oxygen; 380 mOsm/kg osmolality; 7.2 pH; 0.05 vvm sparging). 5 
Run identifier Dissolved 
oxygen (%) 
Osmolality 
(mOsm/kg) 
pH Sparging (vvm) 
Run 1 50 380 7.2 0.05 
Run 2 10 380 7.2 0.05 
Run 3 90 380 7.2 0.05 
Run 4 50 350 7.2 0.05 
Run 6 50 450 7.2 0.05 
Run 7 50 380 7.0 0.05 
Run 8 50 380 7.5 0.05 
Run 9 50 380 8.0 0.05 
Run 10 50 380 7.2 0.05 
Run 11 50 380 7.2 0.10 
Run 12 50 380 7.2 0.20 
Run 13 
(Validation) 
50 420 7.2 0.05 
Run 5 
(Validation 
50 380 7.2 0.05 
  6 
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Table 3: Parameters of multivariate analysis carried out on process data. For each 1 
analysis (column 1) the input data (column 2), the MVDA technique (column 3), the 2 
number of PCs/LVs (column 4) and the cumulative variance explained (column 5) are 3 
shown. 4 
 Multivariate 
technique 
Number of 
PCs/LVs 
Cumulative variance 
explained 
Exploratory 
Analysis 
Online process 
data 
MPCA 6 83.42 
Amino acid data MPCA 4 91.77 
Glycosylation data MPCA 3 90.25 
Glycosylation 
regression 
Model one 
(Predicted from 
titre) 
MPLS 4 X (87.48) 
Y (75.57) 
Model two 
(Predicted from 
titre and glucose) 
MPLS 4 X (95.39) 
Y (70.36) 
Model three 
(Predicted from 
Amino Acids) 
MPLS 4 X (88.74) 
Y (76.95) 
Model four 
(Predicted from 
Online data) 
MPLS 4 X (80.23) 
Y (71.73) 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
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Table 4: Root mean squared error (RMSE) of the (M)PLS regression models. For each 1 
model the input and output data are shown with the RMSE calculated either as an 2 
average value of the whole cultivation for both validation runs (titre prediction model) 3 
or as an average value at the end of the cultivation for both validation runs for each 4 
glycan form (glycosylation prediction). The number of LVs in each model is also 5 
shown. 6 
 
X data Y data 
Root Mean Squared Error 
(RMSE) 
LV 
 
 Amino 
Acids 
Titre 
(max.value= 
100.93 mg/ml) 
6.92 
(average over whole cultivation) 
4 
 
 
Glycan forms  
 A B C D E F G H I 
Model 
1 
Titre Glycosylation 1.67 7.82 10.2 9.34 0.33 0.55 2.41 0.86 1.22 4 
Model 
2 
Titre, 
glucose 
Glycosylation 1.09 3.90 3.37 2.57 0.23 0.68 0.77 0.21 0.06 4 
Model 
3 
Amino 
Acid 
Glycosylation 0.77 2.77 0.67 0.78 0.15 0.40 0.48 0.27 0.50 4 
Model 
4 
Online 
data 
Glycosylation 2.53 34.5 38.0 21.8 0.59 0.51 8.65 7.51 9.93 4 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
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 1 
 2 
 3 
  4 
Figure 1: Bivariate scores plots for 
online process data showing the first 
three principal components. A-C whole 
cultivation data, D-F data post shift in 
operating variable (see symbols and 
Table 1) 
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Figure 2: Bivariate scores plot for amino acid data collected following the shift in 
operating conditions showing the first three principal components 
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Figure 3: Coefficients (loadings) for PCA analysis of amino acid data. Loadings are colour coded 
to show experimental runs 
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Figure 4: PLS predictions for titre from amino acid data for the two validation 
cultivations. (A) run 13 (Table 2) and (B) run 5 (Table 2). Measured values (black 
symbols) and predicted values (open symbols) are shown for each run as their 
absolute values in mg/L, together with experimental error bars. 
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Figure 5: PLS predictions for glycosylation profile from titre and 
glucose post shift (Model 2). Predictions for training runs (black circle) 
and validation runs (open circle) are shown on x-axis vs the actual 
values on y-axis for each of the nine glycan forms measured as % peak 
area (A-I). (A) G0; (B) G0F; (C) G1F; (D) G2F; (E) G0-GalS; (F) G2F-Gal; 
(G) G2F-S; (H) G2F-GalS; (I) G2F-S2. The line represents the parity line 
(prediction = measure value). 
0 1 2 3 4
0
1
2
3
4
20 25 30 35
20
25
30
35
  y y    
25 30 35
25
30
35
6 7 8 9 10
6
7
8
9
10
M
e
a
s
u
re
d
 G
ly
c
o
s
y
la
ti
o
n
 V
a
lu
e
1 1.2 1.4 1.6 1.8 2
1
1.2
1.4
1.6
1.8
2
3 3.5 4 4.5 5 5.5 6
3
4
5
6
4 5 6 7 8
4
5
6
7
8
2 2.2 2.4 2.6 2.8 3
2
2.2
2.4
2.6
2.8
3
Predicted Glycosylation Value
3 3.5 4 4.5 5 5.5 6
3
4
5
6
Page 30 of 32 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
  22 
0 1 2 3 4
0
1
2
3
4
20 25 30 35
20
25
30
35
25 30 35
25
30
35
6 7 8 9 10
6
7
8
9
10
M
e
a
s
u
re
d
 G
ly
c
o
s
y
la
ti
o
n
 V
a
lu
e
1 1.2 1.4 1.6 1.8 2
1
1.2
1.4
1.6
1.8
2
2 3 4 5 6
2
3
4
5
6
4 5 6 7 8
4
5
6
7
8
2 2.2 2.4 2.6 2.8 3
2
2.2
2.4
2.6
2.8
3
Predicted Glycosylation Value
3 3.5 4 4.5 5 5.5 6
3
4
5
6
Figure 6: PLS predictions for glycosylation profile from amino acid 
concentrations post shift (Model 3). Predictions for training runs (black 
circle) and validation runs (open circle) are shown on x-axis vs the 
actual values on y-axis for each of the nine glycan forms measured as 
% peak area (A-I). (A) G0; (B) G0F; (C) G1F; (D) G2F; (E) G0-GalS; (F) 
G2F-Gal; (G) G2F-S; (H) G2F-GalS; (I) G2F-S2. The line represents the 
parity line (prediction = measure value). 
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Figure 1S: PARAFAC analysis of a 3D online data matrix. (A) Mode one, 
representing time of cultivation, with the x-axis showing dimensionless time; 
(B) Mode two, representing online variable recorded, where (1) DO, (2) O2 (3) 
CO2 (4) pH (5) Base (6) Stirrer Speed (7) Temperature; (C) Mode three, 
representing batch number on x axis (see Table 1). Component (1) = red;  
Component (2) = yellow; Component (3) = blue. 
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 1 
 2 
 3 
Figure 2S: PLS predictions for glycosylation profile from online data post shift (Model 4). 4 
Predictions for training runs (black circle) and validation runs (open circle) are shown on x-5 
axis vs the actual values on y-axis for each of the nine glycan forms measured as % peak 6 
area (A-I). (A) G0; (B) G0F; (C) G1F; (D) G2F; (E) G0-GalS; (F) G2F-Gal; (G) G2F-S; (H) 7 
G2F-GalS; (I) G2F-S2. The line represents the parity line (prediction = measure value). 8 
 9 
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